ESC 365 - What do we know from cardiovascular outcomes trials in obesity?

ESC Premium Access

What do we know from cardiovascular outcomes trials in obesity?

Session: Improving cardiovascular risk in patients with obesity

Topic: Obesity

Speaker: Doctor E. Bohula (Boston, US)

Sponsored by Novo Nordisk A/S

Event: ESC Congress 2019

Congress Presentation

About the speaker

Doctor Erin Bohula

Brigham and Women's Hospital, Boston (United States of America)

10 presentations

0 follower

4 more presentations in this session

Chair's welcome

Speaker: Professor L. Ryden (Stockholm, SE)

Does weight loss affect cardiovascular risk?

Speaker: Professor N. Sattar (Glasgow, GB)

The major threat of our time: the global interrelation between obesity, type 2 diabetes and cardiovascular disease

Speaker: Professor L. Ryden (Stockholm, SE)

Connecting with the speakers - Questions and answers

Speaker: Professor L. Ryden (Stockholm, SE) Professor N. Sattar (Glasgow, GB) Doctor E. Bohula (Boston, US)

Access the full session

Improving cardiovascular risk in patients with obesity

Speakers: Doctor E. Bohula, Professor L. Ryden, Professor N. Sattar, Professor L. Ryden, Professor L. Ryden...

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by